Report cover image

Veterinary Vaccines Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)),

Publisher Coherent Market Insights
Published Sep 26, 2022
Length 220 Pages
SKU # CMI17490130

Description

Veterinary Vaccines Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Veterinary/Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Veterinary vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. It also plays an important role in curtailing incidence of transmission of various diseases from animals to humans.

Veterinary vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, and subunit and DNA (Deoxyribonucleic acid) vaccines. Veterinary vaccines impact animal health and production quality and also ensure good health of general human population through consumption of various food procured from animals.

Market Dynamics

Growth of market is driven majorly by the increase in companion animal population, rising incidence of zoonotic diseases (diseases which are transferred from animals to people), initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products, which are driving growth of market. Moreover, increase in the prevalence of veterinary diseases is expected to drive the veterinary vaccine market growth during the forecast period. For instance, according to International Journal of Current Microbiology and Applied Sciences, as of July 10, 2020, number of cases of Sheep & Goat pox in India has increased from 913 cases per year to 3376 cases per year. Thus increasing prevalence of livestock diseases is expected to propel the market growth over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global veterinary vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Zoetis, Inc., Eli Lilly and Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccine market
Detailed Segmentation:
  • Global Veterinary Vaccine Market, By Technology:
  • Inactivated Vaccines
  • Toxoid Vaccine
  • Live Attenuated Vaccines
  • Subunit and DNA Vaccines
  • Global Veterinary vaccine Market, By Animal Type:
  • Companion
  • Equine
  • Canine
  • Feline
  • Livestock
  • Bovine
  • Ovine
  • Porcine
  • Poultry
  • Others
  • Global Veterinary vaccine Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Aratana Therapeutics, Inc.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Regeneus Ltd.
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Zoetis, Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

220 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Technology
Market Snapshot, By Animal Type
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis
4. Global Veterinary Vaccine Market- Impact of Coronavirus (Covid-19) Pandemic
Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market
5. Global Veterinary Vaccine Market, By Technology, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Inactivated Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Toxoid Vaccine
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Live Attenuated Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Subunit and DNA Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Veterinary Vaccine Market, By Animal Type, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Companion
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Equine
Canine
Feline
Livestock
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Bovine
Ovine
Porcine
Poultry
Others
7. Global Veterinary Vaccine Market, By Region, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Aratana Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Regeneus Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Morphogenesis, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Karyopharm Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zoetis, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Boehringer Ingelheim GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
9. Section
Research Methodology
About Us
*Browse 26 market data tables and 25 figures on "Veterinary Vaccine Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us